Marjon Kallewaard

1.5k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Marjon Kallewaard is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Marjon Kallewaard has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 6 papers in Economics and Econometrics. Recurrent topics in Marjon Kallewaard's work include Cardiac Valve Diseases and Treatments (9 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Clinical practice guidelines implementation (3 papers). Marjon Kallewaard is often cited by papers focused on Cardiac Valve Diseases and Treatments (9 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Clinical practice guidelines implementation (3 papers). Marjon Kallewaard collaborates with scholars based in Netherlands, United States and Canada. Marjon Kallewaard's co-authors include R. Sacha Bhatia, Wendy Levinson, Eve A. Kerr, Sam Shortt, Daniel Wolfson, Matthijs L. Becker, Hubert G. M. Leufkens, Bruno HCh Stricker, Loes E. Visser and Yolanda van der Graaf and has published in prestigious journals such as The Lancet, The American Journal of Cardiology and Journal of Clinical Epidemiology.

In The Last Decade

Marjon Kallewaard

21 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

‘Choosing Wisely’: a growing international campaign

2014 401 citations Wendy Levinson, Marjon Kallewaard et al. BMJ Quality & Safety profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marjon Kallewaard Netherlands	11	483	444	238	177	114	21	1.0k
Sarah Rodgers United Kingdom	18	327 0.7×	205 0.5×	508 2.1×	86 0.5×	111 1.0×	42	1.2k
David T. Liss United States	23	618 1.3×	261 0.6×	327 1.4×	132 0.7×	280 2.5×	70	1.8k
Thomas Isaac United States	13	395 0.8×	173 0.4×	211 0.9×	69 0.4×	50 0.4×	25	971
Janice L. Kwan Canada	17	419 0.9×	170 0.4×	365 1.5×	151 0.9×	211 1.9×	39	1.6k
David W. Bates United States	5	254 0.5×	149 0.3×	422 1.8×	55 0.3×	45 0.4×	11	915
Saverio M. Maviglia United States	15	307 0.6×	112 0.3×	227 1.0×	84 0.5×	53 0.5×	36	1.2k
Mitja Kos Slovenia	20	151 0.3×	313 0.7×	474 2.0×	138 0.8×	106 0.9×	84	1.2k
N. Ma'Luf United States	9	278 0.6×	106 0.2×	508 2.1×	50 0.3×	55 0.5×	10	1.7k
Jim Lloyd United States	5	124 0.3×	136 0.3×	332 1.4×	132 0.7×	34 0.3×	7	1.1k
Leslie Fish United States	13	228 0.5×	414 0.9×	1.2k 4.9×	229 1.3×	110 1.0×	16	1.9k

Countries citing papers authored by Marjon Kallewaard

Since Specialization

Citations

This map shows the geographic impact of Marjon Kallewaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjon Kallewaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjon Kallewaard more than expected).

Fields of papers citing papers by Marjon Kallewaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjon Kallewaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjon Kallewaard. The network helps show where Marjon Kallewaard may publish in the future.

Co-authorship network of co-authors of Marjon Kallewaard

This figure shows the co-authorship network connecting the top 25 collaborators of Marjon Kallewaard. A scholar is included among the top collaborators of Marjon Kallewaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjon Kallewaard. Marjon Kallewaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hooff, Miranda L. van, Marjon Kallewaard, Huib A. Cense, et al.. (2023). Using Existing Clinical Information Models for Dutch Quality Registries to Reuse Data and Follow COUMT Paradigm. Applied Clinical Informatics. 14(2). 326–336. 1 indexed citations

Bhatia, R. Sacha, Wendy Levinson, S. E. D. Shortt, et al.. (2015). Measuring the effect of Choosing Wisely: an integrated framework to assess campaign impact on low-value care. BMJ Quality & Safety. 24(8). 523–531. 111 indexed citations

Levinson, Wendy, Marjon Kallewaard, R. Sacha Bhatia, et al.. (2014). ‘Choosing Wisely’: a growing international campaign. BMJ Quality & Safety. 24(2). 167–174. 401 indexed citations breakdown →

Burgers, Jako, et al.. (2007). [Relationship between volume and quality of care for surgical interventions; results of a literature review].. PubMed. 151(38). 2105–10. 5 indexed citations

Kallewaard, Marjon, et al.. (2007). Prestatie-indicatoren langs de meetlat – het AIRE instrument. TSG - Tijdschrift voor gezondheidswetenschappen. 85(5). 261–264. 13 indexed citations

Becker, Matthijs L., et al.. (2006). Determinants of potential drug–drug interaction associated dispensing in community pharmacies in the Netherlands. Pharmacy World & Science. 29(2). 51–57. 27 indexed citations

Becker, Matthijs L., et al.. (2006). Hospitalisations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidemiology and Drug Safety. 16(6). 641–651. 242 indexed citations

Berg, Marc, et al.. (2005). Feasibility first: Developing public performance indicators on patient safety and clinical effectiveness for Dutch hospitals. Health Policy. 75(1). 59–73. 71 indexed citations

Becker, Matthijs L., et al.. (2005). Potential Determinants of Drug-Drug Interaction Associated Dispensing in Community Pharmacies. Drug Safety. 28(5). 371–378. 50 indexed citations

10.

Steyerberg, Ewout W., et al.. (2003). Clinical prediction rule for 30-day mortality in Bj�rk-Shiley convexo-concave valve replacement. Journal of Clinical Epidemiology. 56(10). 1006–1012. 5 indexed citations

11.

Jong, Wim H. de, Marjon Kallewaard, Robert E. Geertsma, et al.. (2003). Study to determine the presence of antipolymer antibodies in a group of Dutch women with a silicone breast implant.. PubMed. 20(2). 151–60. 12 indexed citations

12.

Kallewaard, Marjon, et al.. (2001). Risks of fracture of Björk-Shiley 60 degree convexo-concave prosthetic heart valves: long-term cohort follow up in the UK, Netherlands and USA.. PubMed. 10(2). 202–9. 6 indexed citations

13.

Steyerberg, Ewout W., Marjon Kallewaard, Yolanda van der Graaf, Lex A. van Herwerden, & J. Dik F. Habbema. (2000). Decision Analyses for Prophylactic Replacement of the Björk-Shiley Convexo-concave Heart Valve:. Medical Decision Making. 20(1). 20–32. 19 indexed citations

14.

Kallewaard, Marjon, Ale Algra, J. Defauw, Diederick E. Grobbee, & Yolanda van der Graaf. (2000). Long-term survival after valve replacement with björk-shiley CC valves∗∗Members of the Netherlands Björk-Shiley Study Group are listed in the Appendix.. The American Journal of Cardiology. 85(5). 598–603. 8 indexed citations

15.

Kallewaard, Marjon, Ale Algra, J. Defauw, & Yolanda van der Graaf. (1999). Which manufacturing characteristics are predictors of outlet strut fracture in large sixty-degree Björk-Shiley convexo-concave mitral valves?. Journal of Thoracic and Cardiovascular Surgery. 117(4). 766–775. 16 indexed citations

16.

Kallewaard, Marjon, Ale Algra, J. Defauw, Diederick E. Grobbee, & Yolanda van der Graaf. (1998). Likelihood of underreporting of outlet strut fracture from examination of the Dutch Björk-Shiley CC cohort. The American Journal of Cardiology. 82(6). 768–773. 10 indexed citations

17.

Kallewaard, Marjon, et al.. (1998). Prophylactic Replacement Of BjÖrk-Shiley Convexo-Concave Valves At Risk Of Strut Fracture. Journal of Thoracic and Cardiovascular Surgery. 115(3). 577–581. 7 indexed citations

18.

Kallewaard, Marjon, J. Defauw, & Yolanda van der Graaf. (1997). Psychological distress among recipients of Björk-Shiley convexo-concave valves: the impact of information. Heart. 78(6). 577–580. 3 indexed citations

19.

Kallewaard, Marjon, Ale Algra, & Yolanda van der Graaf. (1996). Welder identity, weld date, and the risk of outlet strut fracture in Björk-Shiley convexo-concave valves: the Dutch cohort study.. Heart. 76(6). 510–512. 8 indexed citations

20.

Mol, Bas A.J.M. de, et al.. (1994). Single-leg strut fractures in explanted Björk-Shiley valves. The Lancet. 343(8888). 9–12. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact